BIOFORCE NANOSCIENCES HOLDINGS, INC.

Q: Jun 30 2026

Q: Mar 31 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Unregistered Sales of Equity Securities

Regulation FD Disclosure

Other Events

Other Events

Other Events

Changes in Control of Registrant

4.01,9.01

5.02,9.01

8.01

3.02

Other Events

8.01

8.01

8.01

8.01

3.02

8.01

Entry into a Material Definitive Agreement

2.04,9.01

7.01,9.01

No description available

No description available

No description available

No description available

No description available

No description available

No description available

Certification of termination of registration of a class of securities (Section 12(g))

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

Definitive Proxy Statement

No description available

Nexus Capital Investments, Inc.

Nexus Capital Investments, Inc.

Mager Scott

KAISER RICHARD KAISER

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

KAISER RICHARD KAISER

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Donohue Susan

Ferguson Merle

Letter from the SEC

Definitive information statement

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC